Mamegel, Magno .
HRN: 23-93-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CEFTAZIDIME 1GM (VIAL)
09/23/2024
10/07/2024
IV
0.5gm
Q48
Cap CKD PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes